Nirvana Life Sciences Inc.
NIRVF
$0.083
$0.0830.00%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.00K | 40.80K | 36.30K | 115.50K | 96.20K |
| Depreciation & Amortization | -- | -- | -- | 4.50K | 9.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.00K | 40.80K | 36.30K | 140.00K | 120.20K |
| Operating Income | -44.00K | -40.80K | -36.30K | -140.00K | -120.20K |
| Income Before Tax | -55.60K | -44.90K | -41.00K | -256.60K | -174.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.60K | -44.90K | -41.00K | -256.60K | -174.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00 | 200.00 | 100.00 | 200.00 | 1.30K |
| Net Income | -55.40K | -44.80K | -40.90K | -256.30K | -173.40K |
| EBIT | -44.00K | -40.80K | -36.30K | -140.00K | -120.20K |
| EBITDA | -40.80K | -37.50K | -33.00K | -135.50K | -117.20K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.05 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.05 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 4.82M | 4.82M | 4.82M | 4.83M | 4.82M |
| Average Diluted Shares Outstanding | 4.82M | 4.82M | 4.82M | 4.83M | 4.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |